Oncogene - Table of Contents alert Volume 33 Issue 3

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 33, Issue 3 (January 2014) In this issue Review Original Articles Short Communication Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement The new Cancer Gene Therapy CGT has a new editor in chief with a new vision for the journal: Steven K. Libutti, M.D. - Director of Montefiore-Einstein Center for Cancer Care - Associate Director for Clinical Services, Albert Einstein Cancer Center.  Submit your research and be a part of the new Cancer Gene Therapy.   You can follow CGT on Twitter @cgtnature   Review Top MicroRNAs regulate both epithelial-to-mesenchymal transition and cancer stem cells P Ceppi and M E Peter Oncogene 2014 33: 269-278; advance online publication, March 4, 2013; 10.1038/onc.2013.55 Abstract | Full Text Original Articles Top SOX15 is a candidate tumor suppressor in pancreatic cancer with a potential role in Wnt/β-catenin signaling K L Thu, N Radulovich, D D Becker-Santos, L A Pikor, A Pusic, W W Lockwood, W L Lam and M-S Tsao Oncogene 2014 33: 279-288; advance online publication, January 14, 2013; 10.1038/onc.2012.595 Abstract | Full Text NG2-cells are not the cell of origin for murine neurofibromatosis-1 (Nf1) optic glioma A C Solga, S M Gianino and D H Gutmann Oncogene 2014 33: 289-299; advance online publication, January 14, 2013; 10.1038/onc.2012.580 Abstract | Full Text The ARF tumor-suppressor controls Drosha translation to prevent Ras-driven transformation M J Kuchenreuther and J D Weber Oncogene 2014 33: 300-307; advance online publication, January 14, 2013; 10.1038/onc.2012.601 Abstract | Full Text TRIM3, a tumor suppressor linked to regulation of p21Waf1/Cip1 Y Liu, R Raheja, N Yeh, D Ciznadija, A M Pedraza, T Ozawa, E Hukkelhoven, H Erdjument-Bromage, P Tempst, N P Gauthier, C Brennan, E C Holland and A Koff Oncogene 2014 33: 308-315; advance online publication, January 14, 2013; 10.1038/onc.2012.596 Abstract | Full Text The PI3K inhibitor GDC-0941 combines with existing clinical regimens for superior activity in multiple myeloma V Munugalavadla, S Mariathasan, D Slaga, C Du, L Berry, G Del Rosario, Y Yan, M Boe, L Sun, L S Friedman, M Chesi, P Leif Bergsagel and A Ebens Oncogene 2014 33: 316-325; advance online publication, January 14, 2013; 10.1038/onc.2012.594 Abstract | Full Text The Rak/Frk tyrosine kinase associates with and internalizes the epidermal growth factor receptor L Jin and R J Craven Oncogene 2014 33: 326-335; advance online publication, January 14, 2013; 10.1038/onc.2012.589 Abstract | Full Text Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival S Ammoun, L Provenzano, L Zhou, M Barczyk, K Evans, D A Hilton, S Hafizi and C O Hanemann Oncogene 2014 33: 336-346; advance online publication, January 14, 2013; 10.1038/onc.2012.587 Abstract | Full Text Next-generation sequencing of endoscopic biopsies identifies ARID1A as a tumor-suppressor gene in Barrett’s esophagus M M Streppel, S Lata, M DelaBastide, E A Montgomery, J S Wang, M I Canto, A M Macgregor-Das, S Pai, F H M Morsink, G J Offerhaus, E Antoniou, A Maitra and W R McCombie Oncogene 2014 33: 347-357; advance online publication, January 14, 2013; 10.1038/onc.2012.586 Abstract | Full Text Epigenetic reprogramming governs EcSOD expression during human mammary epithelial cell differentiation, tumorigenesis and metastasis M L Teoh-Fitzgerald, M P Fitzgerald, W Zhong, R W Askeland and F E Domann Oncogene 2014 33: 358-368; advance online publication, January 14, 2013; 10.1038/onc.2012.582 Abstract | Full Text Constitutive TLR4 signalling in intestinal epithelium reduces tumor load by increasing apoptosis in APCMin/+ mice Y Li, W L Teo, M J Low, L Meijer, I Sanderson, S Pettersson and G Greicius Oncogene 2014 33: 369-377; advance online publication, January 14, 2013; 10.1038/onc.2012.581 Abstract | Full Text MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine Y Xiang, N Ma, D Wang, Y Zhang, J Zhou, G Wu, R Zhao, H Huang, X Wang, Y Qiao, F Li, D Han, L Wang, G Zhang and X Gao Oncogene 2014 33: 378-386; advance online publication, January 14, 2013; 10.1038/onc.2012.575 Abstract | Full Text MicroRNA-145 inhibits the growth, invasion, metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha H Zhang, J Pu, T Qi, M Qi, C Yang, S Li, K Huang, L Zheng and Q Tong Oncogene 2014 33: 387-397; advance online publication, December 10, 2012; 10.1038/onc.2012.574 Abstract | Full Text Short Communication Top Tyrosine phosphatase PTPα contributes to HER2-evoked breast tumor initiation and maintenance D S Meyer, N Aceto, N Sausgruber, H Brinkhaus, U Müller, C J Pallen and M Bentires-Alj Oncogene 2014 33: 398-402; advance online publication, January 14, 2013; 10.1038/onc.2012.585 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.